BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

9 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
13
(±) cis-Bisamido epoxides: A novel series of potent FXIII-A inhibitors.EBI
University of Leeds
5
Novel insights into structure and function of factor XIIIa-inhibitor tridegin.EBI
University of Bonn
3
Tissue transglutaminase: an emerging target for therapy and imaging.EBI
TBA
16
Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors.EBI
Aston University
106
Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.EBI
Evotec (Uk)
44
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.EBI
TBA
39
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.EBI
TBA
13
3-Substituted imidazo[1,2-d][1,2,4]-thiadiazoles: a novel class of factor XIIIa inhibitors.EBI
Apotex Research
11
Compounds for treatment of hypoproliferative disordersBDB
Lu License